chr1-215877757-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_206933.4(USH2A):c.8681+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,444 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_206933.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.8681+1G>A | splice_donor_variant, intron_variant | Intron 43 of 71 | 1 | NM_206933.4 | ENSP00000305941.3 | |||
USH2A | ENST00000674083.1 | c.8681+1G>A | splice_donor_variant, intron_variant | Intron 43 of 72 | ENSP00000501296.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152126Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461318Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 726986
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74312
ClinVar
Submissions by phenotype
Retinitis pigmentosa 39 Pathogenic:2
- -
- -
Usher syndrome Pathogenic:1
Variant summary: USH2A c.8681+1G>A is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Three predict the variant abolishes the canonical 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 251254 control chromosomes (gnomAD). To our knowledge, no occurrence of c.8681+1G>A in individuals affected with Usher Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Usher syndrome;C5680250:Rare genetic deafness Pathogenic:1
The c.8681+1G>A variant in USH2A has not been previously reported in individuals with hearing loss or Usher syndrome nor in large population studies. This varia nt occurs in the invariant region (+/- 1/2) of the splice consensus sequence and is predicted to cause altered splicing leading to an abnormal or absent protein . The loss of USH2A function is an established disease mechanism in autosomal re cessive Usher syndrome. In summary, this variant meets our criteria to be classi fied as pathogenic for Usher syndrome in an autosomal recessive manner based on the predicted impact of the variant. -
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Pathogenic:1
- -
not provided Pathogenic:1
This sequence change affects a donor splice site in intron 43 of the USH2A gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with Usher syndrome (PMID: 28944237). ClinVar contains an entry for this variant (Variation ID: 228416). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Usher syndrome type 2A Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at